This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
5/8/2023
Conference Operator
Operator
Good day, and thank you for standing by. Welcome to Eclair's Therapeutics first quarter 2023 conference call. At this time, all participants are in a listen-only mode. To ask, there'll be a question and answer session. To ask a question, you'll need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To remove yourself from the queue, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Robert Doody, Head of Investor Relations.
Conference Operator
Operator
Please go ahead.
Robert Doody
Head of Investor Relations
Thank you. I am Robert Doody, Head of Investor Relations for Eclaris.
You're reading a preview of the ACRS Q1 2023 earnings call.
Free account.
Disclaimer